0001209191-15-039579.txt : 20150506
0001209191-15-039579.hdr.sgml : 20150506
20150506183536
ACCESSION NUMBER: 0001209191-15-039579
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150505
FILED AS OF DATE: 20150506
DATE AS OF CHANGE: 20150506
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Auspex Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001454189
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 954862842
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3333 N. TORREY PINES COURT
STREET 2: SUITE 400
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 558-2400
MAIL ADDRESS:
STREET 1: 3333 N. TORREY PINES COURT
STREET 2: SUITE 400
CITY: LA JOLLA
STATE: CA
ZIP: 92037
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GREER R SCOTT
CENTRAL INDEX KEY: 0001211703
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36292
FILM NUMBER: 15838766
MAIL ADDRESS:
STREET 1: 26 WHITE PINE CANYON RD
CITY: PARK CITY
STATE: UT
ZIP: 84060
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-05
1
0001454189
Auspex Pharmaceuticals, Inc.
ASPX
0001211703
GREER R SCOTT
C/O AUSPEX PHARMACEUTICALS, INC.
3333 N. TORREY PINES CT., STE. 400
SAN DIEGO
CA
92037
1
0
0
0
Common Stock
2015-05-05
4
U
0
7190
D
0
D
Stock Option (Right to Buy)
18.13
2015-05-05
4
D
0
20000
D
2024-05-05
Common Stock
20000
0
D
Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated March 29, 2015, among the Issuer, Teva Pharmaceuticals Industries Ltd. ("Parent"), and Aurum Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub") in exchange for a cash consideration of $101.00 per share, without interest, subject to any required withholding of taxes. Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation (the "Merger").
This option, which is fully vested, was cancelled in the Merger in exchange for a cash payment equal to $101.00 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the stock option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger.
/s/ Robert Daniel, Attorney-in-fact
2015-05-05